close

Mankind Pharma raises Rs 1,298 cr from anchor investors ahead of IPO

Canada Pension Plan Investment Board (CPPIB), the Government of Singapore, SBI Multi Cap Fund, and Fidelity Investment Trust were some investors who were allotted shares under the anchor quota

BS Reporter Mumbai
Mankind Pharma

Mankind Pharma | Photo: Website

Listen to This Article

Mankind Pharma on Monday allotted shares worth Rs 1,298 crore to anchor investors.
Canada Pension Plan Investment Board (CPPIB), the Government of Singapore, SBI Multi Cap Fund, and Fidelity Investment Trust were some investors who were allotted shares under the anchor quota. A total of 77 investors participated, which included 16 domestic mutual funds also applied through 41 schemes.

Mankind’s initial public offering (IPO) opens for subscription on Tuesday. The company has set a price range of Rs 1,026 to Rs 1,080 per share for its m Rs 4,326-crore IPO, which is entirely secondary share sale by promoters, global private equity firm Cairnhill and some others.
Shares were allotted at the top-end of the price band to anchor investors.

Also Read

Mankind Pharma IPO to open next week: Check price band, GMP, other details

Is Mankind Pharma IPO worth a subscription? Here's what brokerages suggest

71% IPOs of 2022 at premium; will retail investor euphoria sustain in 2023?

Street signs: Defence stocks may rise, Mankind Pharma IPO, and more

Mankind Pharma's Rs 4,326-crore initial public offering to open April 25

Mankind Pharma's Rs 4,326-crore initial public offering to open April 25

Mankind Pharma IPO to open next week: Check price band, GMP, other details

Sebi takes more stringent approach towards initial public offerings

NSE's IPO plan unapproved by Sebi until pending cases are resolved: Report

IPO of Avalon Technologies subscribed 2.21 times on final day of offer

First Published: Apr 24 2023 | 11:07 PM IST

Explore News